PG-2000 series oligosaccharide derivatives (Progen)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePG-2000 series oligosaccharide derivatives (Progen)
Drug Alias Name2000 series (Progen)PG-2024PG-2046PG-2155PG-2173 +[6] 
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionGlycosaminoglycan inhibitors
TargetsGlycosaminoglycan
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTbg Diagnostics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTbg Diagnostics
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A